Novartis to spin off its Alcon eyecare devices

2 July 2018 - Deborah Wilkes

Archived

Novartis plans to spin off its Alcon eyecare devices division into a separately-traded standalone company with 2017 sales of around USD6.7 billion.

Click tags below for more information on topics:

Alcon Novartis

Annual Subscription Holder?

Sign in to continue reading.
 

Sign In

Back to Industry News

Share this page: